PASHAMYLARAM PENEMS
Gland Pharma shares hit 20% lower circuit after disappointing Q4 resultsGland Pharma's stock prices hit a 20% lower circuit on BSE after the firm reported a 72% YoY drop in net profit to Rs 79 crore in Q4FY23 du...
Gland Pharma net profit down 72% to Rs 79 crore in Q4FY23Gland Pharma on Thursday reported 72% year-on-year (YoY) drop in net profit to Rs 79 crores in Q4FY23 due to production shutdown at one of ...
- Load More